Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
Splicing factor gene mutations are the most frequent mutations found in patients with the myeloid malignancy myelodysplastic syndrome (MDS), suggesting that spliceosomal dysfunction plays a major role in disease pathogenesis. The aberrantly spliced target genes and deregulated cellular pathways asso...
主要な著者: | Pellagatti, A, Boultwood, J |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Elsevier
2016
|
類似資料
-
Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches
著者:: Armstrong, R, 等
出版事項: (2017) -
The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
著者:: Boultwood, J, 等
出版事項: (2014) -
Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
著者:: Pellagatti, A, 等
出版事項: (2017) -
Gene expression profiling in the myelodysplastic syndromes.
著者:: Pellagatti, A, 等
出版事項: (2005) -
Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations
著者:: Johanna Flach, 等
出版事項: (2020-09-01)